Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.

Hingorani DV, Chapelin F, Stares E, Adams SR, Okada H, Ahrens ET.

Magn Reson Med. 2020 Mar;83(3):974-987. doi: 10.1002/mrm.27988. Epub 2019 Oct 21.

PMID:
31631402
2.

Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.

Hingorani DV, Doan MK, Camargo MF, Aguilera J, Song SM, Pizzo D, Scanderbeg DJ, Cohen EEW, Lowy AM, Adams SR, Advani SJ.

Mol Cancer Ther. 2020 Jan;19(1):157-167. doi: 10.1158/1535-7163.MCT-18-1302. Epub 2019 Oct 9.

3.

Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage.

Hingorani DV, Lippert CN, Crisp JL, Savariar EN, Hasselmann JPC, Kuo C, Nguyen QT, Tsien RY, Whitney MA, Ellies LG.

PLoS One. 2018 Sep 24;13(9):e0198464. doi: 10.1371/journal.pone.0198464. eCollection 2018.

4.

Nerve-targeted probes for fluorescence-guided intraoperative imaging.

Hingorani DV, Whitney MA, Friedman B, Kwon JK, Crisp JL, Xiong Q, Gross L, Kane CJ, Tsien RY, Nguyen QT.

Theranostics. 2018 Jul 30;8(15):4226-4237. doi: 10.7150/thno.23084. eCollection 2018.

5.

Detection of Subclinical Arthritis in Mice by a Thrombin Receptor-Derived Imaging Agent.

Friedman B, Whitney MA, Savariar EN, Caneda C, Steinbach P, Xiong Q, Hingorani DV, Crisp J, Adams SR, Kenner M, Lippert CN, Nguyen QT, Guma M, Tsien RY, Corr M.

Arthritis Rheumatol. 2018 Jan;70(1):69-79. doi: 10.1002/art.40316. Epub 2017 Nov 29.

6.

Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.

Hingorani DV, Lemieux AJ, Acevedo JR, Glasgow HL, Kedarisetty S, Whitney MA, Molinolo AA, Tsien RY, Nguyen QT.

Oral Oncol. 2017 Aug;71:156-162. doi: 10.1016/j.oraloncology.2017.06.009. Epub 2017 Jun 27.

7.

A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals.

Hingorani DV, Montano LA, Randtke EA, Lee YS, Cárdenas-Rodríguez J, Pagel MD.

Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):130-8. doi: 10.1002/cmmi.1672. Epub 2015 Dec 3.

8.

A review of responsive MRI contrast agents: 2005-2014.

Hingorani DV, Bernstein AS, Pagel MD.

Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):245-65. doi: 10.1002/cmmi.1629. Epub 2014 Oct 29. Review.

9.

Detecting enzyme activities with exogenous MRI contrast agents.

Hingorani DV, Yoo B, Bernstein AS, Pagel MD.

Chemistry. 2014 Aug 4;20(32):9840-50. doi: 10.1002/chem.201402474. Epub 2014 Jul 2. Review.

10.

Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy.

Hingorani DV, Gonzalez SI, Li JF, Pagel MD.

Sensors (Basel). 2013 Oct 11;13(10):13732-43. doi: 10.3390/s131013732.

11.

A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond.

Hingorani DV, Randtke EA, Pagel MD.

J Am Chem Soc. 2013 May 1;135(17):6396-8. doi: 10.1021/ja400254e. Epub 2013 Apr 23.

Supplemental Content

Loading ...
Support Center